Rankings
▼
Calendar
UTHR Q1 2016 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
UTHR
United Therapeutics Corporation
$24B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$369M
Gross Profit
$368M
99.8% margin
Operating Income
$364M
98.6% margin
Net Income
$236M
63.8% margin
EPS (Diluted)
$4.84
Cash Flow
Operating Cash Flow
$126M
Free Cash Flow
$117M
Stock-Based Comp.
-$145M
Balance Sheet
Total Assets
$2.2B
Total Liabilities
$469M
Stockholders' Equity
$1.7B
Cash & Equivalents
$847M
Revenue Segments
Remodulin
$140M
38%
Tyvaso
$102M
28%
Adcirca
$73M
20%
Orenitram
$40M
11%
Unituxin
$14M
4%
← FY 2016
All Quarters
Q2 2016 →
